journal article·2024-03-08

Cordyceps sinensis Polysaccharide Loaded on Black Phosphorus for Synergistic Immunotherapy and Photothermal Therapy of Cancer

Xiaodong Wang, Wei Chen, Junyang Qi, Zimu Li, Lixuan Xue, Xiaowei Zeng, Wenbin Deng

ACS Applied Nano Materials· Volume 7· Issue 5
Publisher page

Abstract

Cordyceps sinensis is a valuable Chinese medicine, possessing multiple bioactive compounds with diverse pharmacological effects. The extracts of C. sinensis, especially the polysaccharide fraction, can suppress the proliferation of different tumor cells, induce apoptosis, and stimulate antitumor immune responses. However, C. sinensis polysaccharides (CSP) have yet to be characterized, with a rare reporting of their effective doses. Immunotherapy depends on harnessing the inherent ability of the immune system to recognize and eliminate tumor cells. Polarizing the anti-inflammatory M2 tumor-associated macrophages (TAMs) to the pro-inflammatory M1 phenotype is an effective antitumor immunotherapy strategy. We designed a drug delivery system with black phosphorus (BP) nanosheets loaded with CSP for synergistic antitumor photothermal therapy (PTT) and immunotherapy. The BP/CSP@PDA–PEG-FA nanoparticles (NPs) enhanced the polarization of M2 macrophages to the M1 phenotype in vitro and in vivo. Moreover, the NPs inhibited the growth of 4T1 xenografts upon near-infrared (NIR) laser stimulation by causing photothermal ablation of tumor cells and promoting T cell-mediated antitumor immune responses. Therefore, BP/CSP@PDA–PEG-FA NPs are a promising platform for combined PTT and immunotherapy for breast tumors.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China

Key Laboratory of State Administration of Traditional Chinese Medicine, Dongguan HEC Cordyceps R&D Co., Ltd., Dongguan 523850, China

Funding

Guangdong Provincial Department of Science and Technology · Science, Technology and Innovation Commission of Shenzhen Municipality · Guangzhou Science, Technology and Innovation Commission · National Natural Science Foundation of China

References (49)

Show source-provided references
1. 10.1080/07388551.2023.223113910.1080/07388551.2023.2231139 ↗
2. 10.1016/j.jpba.2013.04.02510.1016/j.jpba.2013.04.025 ↗
3. 10.1016/j.jfda.2016.10.02010.1016/j.jfda.2016.10.020 ↗
4. 10.1016/j.jep.2017.12.01210.1016/j.jep.2017.12.012 ↗
5. 10.3390/molecules2808335110.3390/molecules28083351 ↗
6. 10.3389/fimmu.2023.115028710.3389/fimmu.2023.1150287 ↗
7. 10.1002/jbt.2334510.1002/jbt.23345 ↗
8. 10.1016/j.carbpol.2020.11611310.1016/j.carbpol.2020.116113 ↗
9. 10.1016/j.ijbiomac.2019.02.15510.1016/j.ijbiomac.2019.02.155 ↗
10. 10.1016/j.ijbiomac.2017.02.07110.1016/j.ijbiomac.2017.02.071 ↗
11. 10.3390/molecules2719657610.3390/molecules27196576 ↗
12. 10.1016/j.carbpol.2020.11596910.1016/j.carbpol.2020.115969 ↗
13. 10.1016/j.ijbiomac.2020.02.05010.1016/j.ijbiomac.2020.02.050 ↗
14. 10.1016/j.intimp.2011.04.00110.1016/j.intimp.2011.04.001 ↗
15. 10.1038/s41577-019-0269-610.1038/s41577-019-0269-6 ↗
16. 10.3390/polym1004043010.3390/polym10040430 ↗
17. 10.1186/s13045-017-0408-010.1186/s13045-017-0408-0 ↗
18. 10.1186/s13045-017-0430-210.1186/s13045-017-0430-2 ↗
19. 10.1016/j.bioactmat.2020.01.00610.1016/j.bioactmat.2020.01.006 ↗
20. 10.1016/j.imbio.2015.11.01010.1016/j.imbio.2015.11.010 ↗
21. 10.3390/cancers1010036610.3390/cancers10100366 ↗
22. 10.1016/j.cellimm.2017.04.00510.1016/j.cellimm.2017.04.005 ↗
23. 10.7150/thno.3314110.7150/thno.33141 ↗
24. 10.1016/j.bioactmat.2020.08.02410.1016/j.bioactmat.2020.08.024 ↗
25. 10.3389/fchem.2020.0056510.3389/fchem.2020.00565 ↗
26. 10.1039/C8CS00618K10.1039/C8CS00618K ↗
27. 10.1021/jacs.8b0215610.1021/jacs.8b02156 ↗
28. 10.1016/j.ijbiomac.2023.12506410.1016/j.ijbiomac.2023.125064 ↗
29. 10.1016/j.cej.2019.12191710.1016/j.cej.2019.121917 ↗
30. 10.1021/acs.biomac.2c0050610.1021/acs.biomac.2c00506 ↗
31. 10.1021/acsanm.2c0309310.1021/acsanm.2c03093 ↗
32. 10.1021/acsanm.1c0127910.1021/acsanm.1c01279 ↗
33. 10.1002/advs.20180051010.1002/advs.201800510 ↗
34. 10.1016/j.cclet.2023.10834610.1016/j.cclet.2023.108346 ↗
35. 10.1002/adfm.20230724110.1002/adfm.202307241 ↗
36. 10.1126/sciadv.adf409810.1126/sciadv.adf4098 ↗
37. 10.1016/j.biomaterials.2023.12215710.1016/j.biomaterials.2023.122157 ↗
38. 10.1016/j.xcrp.2022.10089810.1016/j.xcrp.2022.100898 ↗
39. 10.1007/s10068-017-0008-310.1007/s10068-017-0008-3 ↗
40. 10.1038/168167a010.1038/168167a0 ↗
41. 10.1093/jaoac/49.2.48110.1093/jaoac/49.2.481 ↗
42. 10.1016/j.ijbiomac.2015.01.04110.1016/j.ijbiomac.2015.01.041 ↗
43. 10.1002/adma.20140515010.1002/adma.201405150 ↗
44. 10.1039/C7NR05450E10.1039/C7NR05450E ↗
45. 10.1016/j.carbpol.2012.01.03510.1016/j.carbpol.2012.01.035 ↗
46. 10.1016/j.ijbiomac.2018.11.11310.1016/j.ijbiomac.2018.11.113 ↗
47. 10.1016/j.ijbiomac.2019.01.15910.1016/j.ijbiomac.2019.01.159 ↗
48. 10.1016/j.ijbiomac.2009.07.00810.1016/j.ijbiomac.2009.07.008 ↗
49. 10.1016/S0032-3861(96)00504-610.1016/S0032-3861(96)00504-6 ↗